Key Events This Week
2 Mar: New 52-week low at Rs.822.05 amid sustained downtrend
2 Mar: Significant gap down opening of 7.93%
4 Mar: Continued decline with Rs.857.00 close (-1.58%)
6 Mar: Week closes at Rs.865.95 with a modest 1.06% gain

Epigral Ltd is Rated Sell by MarketsMOJO
2026-03-07 10:10:38Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Epigral Ltd Opens with Significant Gap Down Amid Market Concerns
2026-03-02 13:34:28Epigral Ltd, a specialty chemicals company, opened the trading session with a pronounced gap down, reflecting heightened market concerns following a series of negative performance indicators and a downgrade in its mojo grade. The stock’s opening price plunged by 7.93%, marking a fresh 52-week low and continuing a downward trend that has persisted over the past week.
Read full news article
Epigral Ltd Stock Falls to 52-Week Low of Rs 822.05 Amid Continued Downtrend
2026-03-02 13:05:06Epigral Ltd, a key player in the Specialty Chemicals sector, has touched a new 52-week low of Rs.822.05 today, marking a significant decline amid a sustained downward trend. The stock’s performance continues to lag behind its sector and broader market indices, reflecting ongoing pressures on its financial metrics and market valuation.
Read full news article
Epigral Ltd Stock Falls to 52-Week Low of Rs 901.6 Amid Continued Downtrend
2026-02-27 14:36:20Epigral Ltd, a player in the Specialty Chemicals sector, recorded a fresh 52-week low of Rs.901.6 today, marking a significant milestone in its ongoing price decline. The stock has underperformed its sector and broader market indices, reflecting a challenging period for the company’s equity performance.
Read full news article
Epigral Ltd is Rated Sell
2026-02-24 10:11:08Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 24 February 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Epigral Ltd is Rated Sell
2026-02-12 10:11:11Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 12 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news articleEpigral Ltd Falls 4.65% Amid Volatility: 2 Key Trading Days Define Week
2026-02-07 11:02:06
Key Events This Week
2 Feb: Stock hits 52-week low at Rs.933.45 amid ongoing downtrend
3 Feb: Strong intraday rally with 7.8% surge to Rs.1,001.65
4 Feb: Minor correction with a 0.71% decline
5 Feb: Continued downward pressure, closing at Rs.1,003.85
6 Feb: Week ends with a 1.34% drop to Rs.990.40

Epigral Ltd Hits Intraday High with Strong 7.8% Surge on 3 Feb 2026
2026-02-03 12:01:26Epigral Ltd recorded a robust intraday performance on 3 Feb 2026, surging to a day’s high of Rs 1001.65, marking a 7.98% increase from the previous close. The stock outperformed its sector and the broader market, reflecting notable trading momentum within the Specialty Chemicals industry.
Read full news articleAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
27-Feb-2026 | Source : BSEEpigral Limited has informed that the Company is having One-on-One V.C. with Investor / Analyst on 2nd March 2026.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
06-Feb-2026 | Source : BSEEpigral Limited has informed the Exchange about Participation in Conference and One-on-One Meeting with Analyst / Investor on 10.02.2026.
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
03-Feb-2026 | Source : BSEEpigral Limited submits Transcript of Conference Call held on Friday 30th January 2026 for Q3 FY26 - Results.
Corporate Actions
No Upcoming Board Meetings
Epigral Ltd has declared 25% dividend, ex-date: 07 Feb 25
No Splits history available
No Bonus history available
No Rights history available






